From 1996 to 1998, a decline in the rates of donations testing positive for the human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg) was...

Objective. Among the measures likely to reduce the risk of transmission of the agent causing the new variant of Creutzfeldt-Jakob disease, excluding blood donations from donors who had...

- A decline in HIV prevalence among blood donors through 1998, followed by stabilization at around 0.5 per 10,000 new donors between 1998 and 2005. - Stability in HIV incidence among...

The objective of this article is to analyze trends in the residual risk of HIV transmission, HCV, and HBV, over nine three-year periods from 1992–1994 to 1999–2002 and, for HIV and HCV,...

Viral genomic screening (VGS) for HIV-1 and HCV was introduced in France on July 1, 2001, with the aim of enhancing transfusion safety by reducing the residual risk posed by the...

Changes in the residual viral risk associated with labile blood products are an important indicator for assessing the impact of measures aimed at improving viral safety in blood...

This study analyzes trends in the residual risk of transmission of HIV, HBV, and HCV through blood transfusion over eight three-year periods from 1992 to 2001 and compares, for HIV and...

Key Points Acute Respiratory Infections The 2025–2026 winter season in the Centre-Val de Loire region followed a pattern generally consistent with national trends, characterized by...

Key Points Dengue Dengue activity has been low over the past two weeks. An increase in emergency department visits for dengue has been observed in S16 at CHOG, likely linked to the...